7.35M Want to watch this again later? Sign in to add this video to a playlist. Sign in Like this video? Sign in to make your opinion count. Sign in Don't like this video? Sign in to make your opinion count. Sign in Published on Apr 15, 2020After recovering from a frightening case of coronavirus,…
The coronavirus has not been selective with its targets. And each case is its own story. When to use ventilators in critical cases, for example, differs from patient to patient. So what does it feel like to have COVID-19? What exactly happens in the body, and are there any long-term health effects?For more detail on…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.COVID-19 patients may be contagious with coronavirus two to three days before their symptoms show, according to a research study in China.The research was published Wednesday in the journal Nature Medicine. “Patients with the respiratory disease COVID-19 may begin to shed, or excrete,…
Share on PinterestThe data that are available so far indicate that there are significant differences between how the sexes respond to the new coronavirus.There are many ways in which the pandemic itself affects people’s day-to-day lives, and gender — understood as the ensemble of social expectations, norms, and roles we associate with being a man,…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.